GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (SGX:H02) » Definitions » Institutional Ownership

Haw Par (SGX:H02) Institutional Ownership : 19.38% (As of Jun. 10, 2024)


View and export this data going back to 1969. Start your Free Trial

What is Haw Par Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Haw Par's institutional ownership is 19.38%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Haw Par's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Haw Par's Float Percentage Of Total Shares Outstanding is 0.00%.


Haw Par Institutional Ownership Historical Data

The historical data trend for Haw Par's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Institutional Ownership Chart

Haw Par Historical Data

The historical data trend for Haw Par can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 19.53 19.64 19.69 19.72 19.69 19.69 19.42 19.39 19.38 19.38

Haw Par Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Haw Par (SGX:H02) Business Description

Traded in Other Exchanges
Address
401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (SGX:H02) Headlines

No Headlines